annual retained earnings:
-$1.63B-$599.49M(-58.43%)Summary
- As of today (May 29, 2025), ARWR annual retained earnings is -$1.63 billion, with the most recent change of -$599.49 million (-58.43%) on September 30, 2024.
- During the last 3 years, ARWR annual retained earnings has fallen by -$980.83 million (-152.14%).
- ARWR annual retained earnings is now -1707382.14% below its all-time high of -$95.20 thousand, reached on September 30, 2003.
Performance
ARWR Retained earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly retained earnings:
-$1.43B+$370.44M(+20.60%)Summary
- As of today (May 29, 2025), ARWR quarterly retained earnings is -$1.43 billion, with the most recent change of +$370.44 million (+20.60%) on March 31, 2025.
- Over the past year, ARWR quarterly retained earnings has dropped by -$143.97 million (-11.21%).
- ARWR quarterly retained earnings is now -1500071.22% below its all-time high of -$95.20 thousand, reached on September 30, 2003.
Performance
ARWR quarterly retained earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Retained earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
ARWR Retained earnings Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -58.4% | -11.2% |
3 y3 years | -152.1% | -115.3% |
5 y5 years | -287.7% | -223.3% |
ARWR Retained earnings Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -152.1% | at low | -115.3% | +20.6% |
5 y | 5-year | -287.7% | at low | -223.3% | +20.6% |
alltime | all time | <-9999.0% | at low | <-9999.0% | +20.6% |
ARWR Retained earnings History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | -$1.43B(-20.6%) |
Dec 2024 | - | -$1.80B(+10.6%) |
Sep 2024 | -$1.63B(+58.4%) | -$1.63B(+11.7%) |
Jun 2024 | - | -$1.45B(+13.3%) |
Mar 2024 | - | -$1.28B(+10.8%) |
Dec 2023 | - | -$1.16B(+12.9%) |
Sep 2023 | -$1.03B(+25.0%) | -$1.03B(+12.0%) |
Jun 2023 | - | -$916.35M(+12.7%) |
Mar 2023 | - | -$813.40M(-5.6%) |
Dec 2022 | - | -$862.08M(+5.0%) |
Sep 2022 | -$820.75M(+27.3%) | -$820.75M(+11.6%) |
Jun 2022 | - | -$735.24M(+10.9%) |
Mar 2022 | - | -$663.20M(-6.3%) |
Dec 2021 | - | -$707.56M(+9.8%) |
Sep 2021 | -$644.69M(+28.0%) | -$644.69M(+10.9%) |
Jun 2021 | - | -$581.32M(+5.4%) |
Mar 2021 | - | -$551.39M(+5.1%) |
Dec 2020 | - | -$524.58M(+4.1%) |
Sep 2020 | -$503.84M(+20.2%) | -$503.84M(+10.6%) |
Jun 2020 | - | -$455.41M(+3.1%) |
Mar 2020 | - | -$441.80M(+4.7%) |
Dec 2019 | - | -$421.96M(+0.6%) |
Sep 2019 | -$419.29M(-14.0%) | -$419.29M(-2.7%) |
Jun 2019 | - | -$431.00M(-4.5%) |
Mar 2019 | - | -$451.33M(-5.0%) |
Dec 2018 | - | -$475.23M(-2.5%) |
Sep 2018 | -$487.27M(+12.6%) | -$487.27M(+2.3%) |
Jun 2018 | - | -$476.50M(+3.4%) |
Mar 2018 | - | -$460.90M(+3.3%) |
Dec 2017 | - | -$446.01M(+3.0%) |
Sep 2017 | -$432.82M(+8.6%) | -$432.82M(+2.5%) |
Jun 2017 | - | -$422.08M(+1.3%) |
Mar 2017 | - | -$416.56M(+1.5%) |
Dec 2016 | - | -$410.52M(+3.0%) |
Sep 2016 | -$398.44M(+25.8%) | -$398.44M(+5.9%) |
Jun 2016 | - | -$376.21M(+5.4%) |
Mar 2016 | - | -$356.79M(+6.2%) |
Dec 2015 | - | -$335.98M(+6.1%) |
Sep 2015 | -$316.71M(+40.9%) | -$316.71M(+8.5%) |
Jun 2015 | - | -$291.97M(+5.8%) |
Mar 2015 | - | -$276.03M(+11.6%) |
Dec 2014 | - | -$247.35M(+10.0%) |
Sep 2014 | -$224.77M(+35.3%) | -$224.77M(+11.1%) |
Jun 2014 | - | -$202.34M(+6.1%) |
Mar 2014 | - | -$190.71M(+7.9%) |
Dec 2013 | - | -$176.77M(+6.4%) |
Sep 2013 | -$166.14M(+23.1%) | -$166.14M(+9.0%) |
Jun 2013 | - | -$152.45M(+4.2%) |
Mar 2013 | - | -$146.37M(+4.8%) |
Dec 2012 | - | -$139.61M(+3.4%) |
Sep 2012 | -$135.00M | -$135.00M(+4.1%) |
Jun 2012 | - | -$129.68M(+6.6%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2012 | - | -$121.69M(+4.6%) |
Dec 2011 | - | -$116.36M(+2.2%) |
Sep 2011 | -$113.87M(+2.8%) | -$113.87M(+2.5%) |
Jun 2011 | - | -$111.10M(+1.7%) |
Mar 2011 | - | -$109.28M(-2.6%) |
Dec 2010 | - | -$112.18M(+1.3%) |
Sep 2010 | -$110.74M(+5.5%) | -$110.74M(+1.8%) |
Jun 2010 | - | -$108.74M(+0.3%) |
Mar 2010 | - | -$108.37M(+1.7%) |
Dec 2009 | - | -$106.51M(+1.5%) |
Sep 2009 | -$104.97M(+22.8%) | -$104.97M(+3.6%) |
Jun 2009 | - | -$101.34M(+2.6%) |
Mar 2009 | - | -$98.82M(+5.7%) |
Dec 2008 | - | -$93.53M(+9.4%) |
Sep 2008 | -$85.50M(+46.4%) | -$85.50M(+11.3%) |
Jun 2008 | - | -$76.84M(+10.8%) |
Mar 2008 | - | -$69.34M(+8.9%) |
Dec 2007 | - | -$63.64M(+9.0%) |
Sep 2007 | -$58.41M(+105.1%) | -$58.41M(+14.9%) |
Jun 2007 | - | -$50.83M(+32.5%) |
Mar 2007 | - | -$38.36M(+19.2%) |
Dec 2006 | - | -$32.18M(+13.0%) |
Sep 2006 | -$28.48M(+200.4%) | -$28.48M(+44.6%) |
Jun 2006 | - | -$19.70M(+25.3%) |
Mar 2006 | - | -$15.72M(+24.6%) |
Dec 2005 | - | -$12.62M(+33.1%) |
Sep 2005 | -$9.48M(+265.7%) | -$9.48M(+45.3%) |
Jun 2005 | - | -$6.52M(+87.1%) |
Mar 2005 | - | -$3.49M(-15.6%) |
Dec 2004 | - | -$4.13M(+59.3%) |
Sep 2004 | -$2.59M(+2622.9%) | -$2.59M(+132.4%) |
Jun 2004 | - | -$1.12M(+133.7%) |
Mar 2004 | - | -$477.10K(+58.4%) |
Dec 2003 | - | -$301.20K(+216.4%) |
Sep 2003 | -$95.20K(-99.0%) | -$95.20K(-99.0%) |
Jun 2003 | - | -$9.82M(+0.5%) |
Mar 2003 | - | -$9.76M(+1.1%) |
Dec 2002 | - | -$9.66M(+0.5%) |
Sep 2002 | -$9.61M(+2.6%) | -$9.61M(+0.9%) |
Jun 2002 | - | -$9.53M(+0.9%) |
Mar 2002 | - | -$9.44M(+0.1%) |
Dec 2001 | - | -$9.43M(+0.7%) |
Sep 2001 | -$9.37M(+2.0%) | -$9.37M(+0.7%) |
Jun 2001 | - | -$9.31M(+0.4%) |
Mar 2001 | - | -$9.27M(+0.6%) |
Dec 2000 | - | -$9.22M(+0.4%) |
Sep 2000 | -$9.18M(+1.5%) | -$9.18M(-0.4%) |
Jun 2000 | - | -$9.22M(+0.6%) |
Mar 2000 | - | -$9.16M(+0.6%) |
Dec 1999 | - | -$9.10M |
Sep 1999 | -$9.04M(-6.2%) | - |
Sep 1998 | -$9.64M(+2.4%) | - |
Sep 1997 | -$9.41M | - |
FAQ
- What is Arrowhead Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals annual retained earnings year-on-year change?
- What is Arrowhead Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals quarterly retained earnings year-on-year change?
What is Arrowhead Pharmaceuticals annual retained earnings?
The current annual retained earnings of ARWR is -$1.63B
What is the all time high annual retained earnings for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high annual retained earnings is -$95.20K
What is Arrowhead Pharmaceuticals annual retained earnings year-on-year change?
Over the past year, ARWR annual retained earnings has changed by -$599.49M (-58.43%)
What is Arrowhead Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of ARWR is -$1.43B
What is the all time high quarterly retained earnings for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high quarterly retained earnings is -$95.20K
What is Arrowhead Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, ARWR quarterly retained earnings has changed by -$143.97M (-11.21%)